Goldman Sachs Group Inc - Jun 30, 2025 SCHEDULE 13G/A Report for FATE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (FATE)

Filing Manager: GOLDMAN SACHS GROUP INC
Reporting Manager: THE GOLDMAN SACHS GROUP, INC.
Security: FATE THERAPEUTICS, INC. Common Stock, par value $0.001 per share
Symbol: FATE
Shares outstanding: 114M shares
Disclosed Ownership: 2.27M shares
Ownership: 2%
Form type: SCHEDULE 13G/A
Date filed: 8/14/2025, 11:30 AM
Date of event: Jun 30, 2025
Previous filing: May 9, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	2%	2.27M	0	2.27M	Name: Veronica Mupazviriwo	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	2%	2.27M	0	2.27M	Name: Veronica Mupazviriwo	Attorney-in-fact